Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne Pollution

NCT04132570 is registered in ClinicalTrials.gov with Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division as lead sponsor.

NCT NCT04132570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04132570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne Pollution
Lead sponsor
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
Phase
Phase 4
Overall status
Completed
Start date
October 22, 2019
Completion date
January 22, 2020
Enrollment
206 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

rhinitis